These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

571 related items for PubMed ID: 26377465

  • 1. Amyloid β Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases.
    Brkic M, Balusu S, Van Wonterghem E, Gorlé N, Benilova I, Kremer A, Van Hove I, Moons L, De Strooper B, Kanazir S, Libert C, Vandenbroucke RE.
    J Neurosci; 2015 Sep 16; 35(37):12766-78. PubMed ID: 26377465
    [Abstract] [Full Text] [Related]

  • 2. Aβ₁₋₄₂-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca²⁺-calcineurin signaling.
    Kook SY, Hong HS, Moon M, Ha CM, Chang S, Mook-Jung I.
    J Neurosci; 2012 Jun 27; 32(26):8845-54. PubMed ID: 22745485
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Choroid plexus genes for CSF production and brain homeostasis are altered in Alzheimer's disease.
    Kant S, Stopa EG, Johanson CE, Baird A, Silverberg GD.
    Fluids Barriers CNS; 2018 Dec 12; 15(1):34. PubMed ID: 30541599
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Gene expression and functional annotation of human choroid plexus epithelium failure in Alzheimer's disease.
    Bergen AA, Kaing S, ten Brink JB, Netherlands Brain Bank, Gorgels TG, Janssen SF.
    BMC Genomics; 2015 Nov 16; 16():956. PubMed ID: 26573292
    [Abstract] [Full Text] [Related]

  • 8. Aβ(1-42) oligomer-induced leakage in an in vitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins.
    Wan W, Cao L, Liu L, Zhang C, Kalionis B, Tai X, Li Y, Xia S.
    J Neurochem; 2015 Jul 16; 134(2):382-93. PubMed ID: 25866188
    [Abstract] [Full Text] [Related]

  • 9. Increased beta-amyloid levels in the choroid plexus following lead exposure and the involvement of low-density lipoprotein receptor protein-1.
    Behl M, Zhang Y, Monnot AD, Jiang W, Zheng W.
    Toxicol Appl Pharmacol; 2009 Oct 15; 240(2):245-54. PubMed ID: 19501112
    [Abstract] [Full Text] [Related]

  • 10. The choroid plexus-cerebrospinal fluid interface in Alzheimer's disease: more than just a barrier.
    Balusu S, Brkic M, Libert C, Vandenbroucke RE.
    Neural Regen Res; 2016 Apr 15; 11(4):534-7. PubMed ID: 27212900
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of cationic drug-sensitive transport systems at the blood-cerebrospinal fluid barrier in para-tyramine elimination from rat brain.
    Akanuma SI, Yamazaki Y, Kubo Y, Hosoya KI.
    Fluids Barriers CNS; 2018 Jan 08; 15(1):1. PubMed ID: 29307307
    [Abstract] [Full Text] [Related]

  • 13. EGb761 provides a protective effect against Aβ1-42 oligomer-induced cell damage and blood-brain barrier disruption in an in vitro bEnd.3 endothelial model.
    Wan WB, Cao L, Liu LM, Kalionis B, Chen C, Tai XT, Li YM, Xia SJ.
    PLoS One; 2014 Jan 08; 9(11):e113126. PubMed ID: 25426944
    [Abstract] [Full Text] [Related]

  • 14. Modeling immune functions of the mouse blood-cerebrospinal fluid barrier in vitro: primary rather than immortalized mouse choroid plexus epithelial cells are suited to study immune cell migration across this brain barrier.
    Lazarevic I, Engelhardt B.
    Fluids Barriers CNS; 2016 Jan 29; 13():2. PubMed ID: 26833402
    [Abstract] [Full Text] [Related]

  • 15. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
    Li S, Jin M, Liu L, Dang Y, Ostaszewski BL, Selkoe DJ.
    Acta Neuropathol Commun; 2018 Nov 08; 6(1):121. PubMed ID: 30409172
    [Abstract] [Full Text] [Related]

  • 16. Circadian rhythmicity of amyloid-beta-related molecules is disrupted in the choroid plexus of a female Alzheimer's disease mouse model.
    Furtado A, Esgalhado AJ, Duarte AC, Costa AR, Costa-Brito AR, Carro E, Ishikawa H, Schroten H, Schwerk C, Gonçalves I, Arosa FA, Santos CRA, Quintela T.
    J Neurosci Res; 2023 Apr 08; 101(4):524-540. PubMed ID: 36583371
    [Abstract] [Full Text] [Related]

  • 17. VEGF receptor-1 modulates amyloid β 1-42 oligomer-induced senescence in brain endothelial cells.
    Singh Angom R, Wang Y, Wang E, Pal K, Bhattacharya S, Watzlawik JO, Rosenberry TL, Das P, Mukhopadhyay D.
    FASEB J; 2019 Mar 08; 33(3):4626-4637. PubMed ID: 30576228
    [Abstract] [Full Text] [Related]

  • 18. Immune response and pathogen invasion at the choroid plexus in the onset of cerebral toxoplasmosis.
    Figueiredo CA, Steffen J, Morton L, Arumugam S, Liesenfeld O, Deli MA, Kröger A, Schüler T, Dunay IR.
    J Neuroinflammation; 2022 Jan 13; 19(1):17. PubMed ID: 35027063
    [Abstract] [Full Text] [Related]

  • 19. The choroid plexus removes beta-amyloid from brain cerebrospinal fluid.
    Crossgrove JS, Li GJ, Zheng W.
    Exp Biol Med (Maywood); 2005 Nov 13; 230(10):771-6. PubMed ID: 16246905
    [Abstract] [Full Text] [Related]

  • 20. Protection of the blood-brain barrier by pentosan against amyloid-β-induced toxicity.
    Deli MA, Veszelka S, Csiszár B, Tóth A, Kittel A, Csete M, Sipos A, Szalai A, Fülöp L, Penke B, Abrahám CS, Niwa M.
    J Alzheimers Dis; 2010 Nov 13; 22(3):777-94. PubMed ID: 20847411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.